Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,356 | 32 | 70.8% |
| Food and Beverage | $16,250 | 875 | 27.8% |
| Travel and Lodging | $797.49 | 7 | 1.4% |
| Education | $28.61 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $41,888 | 125 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $2,339 | 36 | $0 (2023) |
| Dexcom, Inc. | $1,420 | 54 | $0 (2024) |
| Lilly USA, LLC | $1,289 | 110 | $0 (2024) |
| Novo Nordisk Inc | $1,208 | 96 | $0 (2024) |
| Medtronic MiniMed, Inc. | $951.75 | 68 | $0 (2020) |
| Tandem Diabetes Care, Inc. | $934.94 | 11 | $0 (2020) |
| Valeritas, Inc. | $845.16 | 9 | $0 (2019) |
| Corcept Therapeutics | $734.47 | 33 | $0 (2024) |
| Insulet Corporation | $664.00 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,707 | 134 | Dexcom, Inc. ($473.91) |
| 2023 | $2,021 | 108 | Lilly USA, LLC ($321.67) |
| 2022 | $1,997 | 108 | Novartis Pharmaceuticals Corporation ($301.90) |
| 2021 | $1,030 | 71 | Lilly USA, LLC ($163.21) |
| 2020 | $1,705 | 55 | Amgen Inc. ($877.19) |
| 2019 | $19,477 | 152 | Amgen Inc. ($17,709) |
| 2018 | $12,096 | 146 | Amgen Inc. ($9,079) |
| 2017 | $17,399 | 143 | Amgen Inc. ($13,538) |
All Payment Transactions
917 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Endocrinology | ||||||
| 12/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Durable Pump | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/30/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Endocrinology | ||||||
| 10/14/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/02/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $19.05 | General |
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Endocrinology | ||||||
| 09/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Endocrinology | ||||||
| 09/26/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Endocrinology | ||||||
| 09/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 610 | 1,135 | $186,604 | $76,048 |
| 2022 | 5 | 604 | 1,132 | $186,119 | $78,085 |
| 2021 | 6 | 676 | 1,270 | $210,125 | $94,049 |
| 2020 | 8 | 781 | 1,211 | $200,134 | $77,385 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 343 | 707 | $127,260 | $57,258 | 45.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $19,440 | $7,885 | 40.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 139 | 300 | $28,200 | $6,982 | 24.8% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 28 | 28 | $8,484 | $2,799 | 33.0% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2023 | 28 | 28 | $3,220 | $1,124 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 357 | 737 | $130,343 | $60,290 | 46.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $16,070 | $6,756 | 42.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 131 | 275 | $25,850 | $6,625 | 25.6% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 33 | 37 | $11,211 | $3,584 | 32.0% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2022 | 23 | 23 | $2,645 | $829.85 | 31.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 405 | 882 | $152,586 | $75,109 | 49.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 128 | 243 | $22,842 | $6,235 | 27.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 56 | 56 | $14,822 | $5,710 | 38.5% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2021 | 49 | 51 | $15,453 | $5,314 | 34.4% |
| 95249 | Continuous monitoring of glucose in tissue fluid using sensor under skin | Office | 2021 | 25 | 25 | $2,875 | $993.95 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,547 | $687.31 | 44.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 323 | 622 | $107,606 | $43,664 | 40.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 111 | 111 | $29,380 | $12,208 | 41.6% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2020 | 57 | 67 | $20,301 | $7,106 | 35.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 120 | 146 | $17,374 | $6,656 | 38.3% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 115 | 209 | $19,646 | $5,510 | 28.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $2,798 | $1,093 | 39.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 23 | 24 | $1,877 | $703.75 | 37.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 16 | 16 | $1,152 | $445.57 | 38.7% |
About Dr. Wael Eid, MD
Dr. Wael Eid, MD is a Hospitalist healthcare provider based in Covington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013936517.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wael Eid, MD has received a total of $58,432 in payments from pharmaceutical and medical device companies, with $2,707 received in 2024. These payments were reported across 917 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,356).
As a Medicare-enrolled provider, Eid has provided services to 2,671 Medicare beneficiaries, totaling 4,748 services with total Medicare billing of $325,569. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Diabetes & Metabolism
- Location Covington, KY
- Active Since 07/18/2006
- Last Updated 09/13/2018
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1013936517
Products in Payments
- Repatha (Biological) $41,459
- PRALUENT (Drug) $1,952
- Minimed 670G System (Device) $977.40
- t-slim insulin pump (Device) $911.35
- Dexcom G6 Transmitter (Medical Supply) $852.53
- V-GO (Device) $845.16
- JARDIANCE (Drug) $763.53
- Korlym (Drug) $734.47
- Omnipod (Device) $664.00
- LEQVIO (Drug) $534.59
- Ozempic (Drug) $508.56
- EVKEEZA (Biological) $394.56
- DEXCOM CGM (Device) $353.35
- FREESTYLE LIBRE 3 (Device) $341.35
- HUMULIN (Drug) $278.02
- Vascepa (Drug) $274.32
- SOMAVERT (Drug) $237.65
- MOUNJARO (Drug) $232.88
- TRULICITY (Drug) $223.25
- Belviq (Drug) $207.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Covington
Smita Patel, Md, MD
Hospitalist — Payments: $3,546
Dr. Jane Atallah, Md, MD
Hospitalist — Payments: $685.66
Dr. Maria El Zoghby, Md, MD
Hospitalist — Payments: $168.44
Dr. Clifton Cassidy, D.o, D.O
Hospitalist
Christa Moliniare-Martin, Aprn Fnp, APRN FNP
Hospitalist